Lois J. Arend

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab

R. John Looney, Jennifer H. Anolik, Debbie Campbell et al. · Arthritis & Rheumatism · 2004 · 777 citations

Life Sciences, Immunology, Pharmacotherapy +16

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

Matthew J. Everly, J Everly, Brian Susskind et al. · Transplantation · 2008 · 389 citations

Life Sciences, Immunology, Pharmacotherapy +17

Neointimal Hyperplasia in Early Arteriovenous Fistula Failure

Prabir Roy‐Chaudhury, Lois J. Arend, Jianhua Zhang et al. · American Journal of Kidney Diseases · 2007 · 286 citations

Medicine, Pathology, Surgery +5

Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy

Tao Jiang, Xiaoxin X. Wang, Pnina Scherzer et al. · Diabetes · 2007 · 232 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

M.J. Everlya, J.J. Everlya, Lois J. Arend et al. · American Journal of Transplantation · 2009 · 207 citations · Full text

Life Sciences, Immunology, Surgery +17